GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Long-Term Capital Lease Obligation

Winshine Science Co (HKSE:00209) Long-Term Capital Lease Obligation : HK$1.9 Mil (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Long-Term Capital Lease Obligation?

Winshine Science Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1.9 Mil.

Winshine Science Co's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$2.8 Mil) to Jun. 2023 (HK$1.9 Mil) and declined from Jun. 2023 (HK$1.9 Mil) to Dec. 2023 (HK$1.9 Mil).

Winshine Science Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$8.3 Mil) to Dec. 2022 (HK$2.8 Mil) and declined from Dec. 2022 (HK$2.8 Mil) to Dec. 2023 (HK$1.9 Mil).


Winshine Science Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Winshine Science Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co Long-Term Capital Lease Obligation Chart

Winshine Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 0.53 8.29 2.82 1.86

Winshine Science Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 8.48 2.82 1.88 1.86

Winshine Science Co  (HKSE:00209) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Winshine Science Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Winshine Science Co (HKSE:00209) Business Description

Traded in Other Exchanges
N/A
Address
287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Executives
Wang Honggang 2101 Beneficial owner
U Credit (hk) Limited 2106 Person having a security interest in shares
Csc Holdings Limited 2106 Person having a security interest in shares
Hurray Talent Investment Development Limited 2101 Beneficial owner
Li Zhonghai 2201 Interest of corporation controlled by you
Liu Lian 2201 Interest of corporation controlled by you
Richsun Investment Development Limited 2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited 2101 Beneficial owner
Jiang Qinghui 2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited") 2106 Person having a security interest in shares
China Strategic Holdings Limited 2106 Person having a security interest in shares
Shen Jia 2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines